CMS Suspends Albuterol Payment Cuts Under Medicare Part B
Executive Summary
The Centers for Medicare & Medicaid Services will reconsider Medicare carrier payment reductions for albuterol, the agency's Dec. 13 inherent reasonableness interim final rule says